Pharma Companies Agree to Price Cuts

President Trump and nine major pharmaceutical companies, including AbbVie, have reached an agreement to significantly reduce drug prices. This development is part of a broader effort to make medications more affordable for Americans. The deal aligns with the Trump administration's push to lower healthcare costs through the Most Favored Nation (MFN) pricing model, which aims to align U.S. drug prices with the lowest prices paid by other developed countries. This move marks a substantial step in the administration's healthcare policy, potentially impacting millions of patients and setting a precedent for future pricing negotiations.